ATRENEW INC (RERE) Fundamental Analysis & Valuation

NYSE:RERE • US00138L1089

5.36 USD
-0.43 (-7.43%)
At close: Mar 3, 2026
5.36 USD
0 (0%)
After Hours: 3/3/2026, 8:04:00 PM

This RERE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to RERE. RERE was compared to 123 industry peers in the Specialty Retail industry. While RERE has a great health rating, there are worries on its profitability. RERE is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. RERE Profitability Analysis

1.1 Basic Checks

  • In the past year RERE was profitable.
  • RERE had negative earnings in each of the past 5 years.
  • In multiple years RERE reported negative operating cash flow during the last 5 years.
RERE Yearly Net Income VS EBIT VS OCF VS FCFRERE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

  • RERE has a better Return On Assets (5.34%) than 72.36% of its industry peers.
  • With a decent Return On Equity value of 7.28%, RERE is doing good in the industry, outperforming 62.60% of the companies in the same industry.
  • RERE's Return On Invested Capital of 6.73% is fine compared to the rest of the industry. RERE outperforms 65.04% of its industry peers.
Industry RankSector Rank
ROA 5.34%
ROE 7.28%
ROIC 6.73%
ROA(3y)-17.29%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
RERE Yearly ROA, ROE, ROICRERE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.44%, RERE is in line with its industry, outperforming 56.10% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 1.72%, RERE is in line with its industry, outperforming 48.78% of the companies in the same industry.
  • The Gross Margin of RERE (12.19%) is worse than 86.18% of its industry peers.
  • In the last couple of years the Gross Margin of RERE has grown nicely.
Industry RankSector Rank
OM 1.72%
PM (TTM) 1.44%
GM 12.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y35.7%
RERE Yearly Profit, Operating, Gross MarginsRERE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

7

2. RERE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), RERE is destroying value.
  • The number of shares outstanding for RERE has been reduced compared to 1 year ago.
  • The number of shares outstanding for RERE remains at a similar level compared to 5 years ago.
  • RERE has a better debt/assets ratio than last year.
RERE Yearly Shares OutstandingRERE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
RERE Yearly Total Debt VS Total AssetsRERE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • There is no outstanding debt for RERE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.79
WACC8.52%
RERE Yearly LT Debt VS Equity VS FCFRERE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 3.30 indicates that RERE has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.30, RERE belongs to the top of the industry, outperforming 90.24% of the companies in the same industry.
  • RERE has a Quick Ratio of 2.77. This indicates that RERE is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 2.77, RERE belongs to the top of the industry, outperforming 93.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.77
RERE Yearly Current Assets VS Current LiabilitesRERE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. RERE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 441.18% over the past year.
  • The Revenue has grown by 27.94% in the past year. This is a very strong growth!
  • RERE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.94% yearly.
EPS 1Y (TTM)441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.62%
Revenue 1Y (TTM)27.94%
Revenue growth 3Y28.03%
Revenue growth 5Y32.94%
Sales Q2Q%27.1%

3.2 Future

  • Based on estimates for the next years, RERE will show a very strong growth in Earnings Per Share. The EPS will grow by 180.68% on average per year.
  • RERE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.48% yearly.
EPS Next Y531.48%
EPS Next 2Y231.38%
EPS Next 3Y180.68%
EPS Next 5YN/A
Revenue Next Year28.57%
Revenue Next 2Y26.78%
Revenue Next 3Y25.48%
Revenue Next 5YN/A

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RERE Yearly Revenue VS EstimatesRERE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B
RERE Yearly EPS VS EstimatesRERE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4

4

4. RERE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 28.21, the valuation of RERE can be described as expensive.
  • Based on the Price/Earnings ratio, RERE is valued a bit cheaper than the industry average as 62.60% of the companies are valued more expensively.
  • RERE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 18.36, the valuation of RERE can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of RERE indicates a somewhat cheap valuation: RERE is cheaper than 67.48% of the companies listed in the same industry.
  • RERE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.21
Fwd PE 18.36
RERE Price Earnings VS Forward Price EarningsRERE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • RERE's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.82
RERE Per share dataRERE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • RERE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as RERE's earnings are expected to grow with 180.68% in the coming years.
PEG (NY)0.05
PEG (5Y)N/A
EPS Next 2Y231.38%
EPS Next 3Y180.68%

0

5. RERE Dividend Analysis

5.1 Amount

  • No dividends for RERE!.
Industry RankSector Rank
Dividend Yield 0%

RERE Fundamentals: All Metrics, Ratios and Statistics

ATRENEW INC

NYSE:RERE (3/3/2026, 8:04:00 PM)

After market: 5.36 0 (0%)

5.36

-0.43 (-7.43%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-20
Earnings (Next)03-09
Inst Owners41.44%
Inst Owner Change9.43%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.19B
Revenue(TTM)19.64B
Net Income(TTM)283.00M
Analysts85
Price Target7.57 (41.23%)
Short Float %1.32%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.98%
Min EPS beat(2)-29.48%
Max EPS beat(2)-26.47%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.47%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)2.05%
Revenue beat(4)1
Avg Revenue beat(4)-0.31%
Min Revenue beat(4)-1.18%
Max Revenue beat(4)2.05%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)48.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)394.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 28.21
Fwd PE 18.36
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.12
EV/EBITDA 13.82
EPS(TTM)0.19
EY3.54%
EPS(NY)0.29
Fwd EY5.45%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS12.83
BVpS2.54
TBVpS2.53
PEG (NY)0.05
PEG (5Y)N/A
Graham Number3.29
Profitability
Industry RankSector Rank
ROA 5.34%
ROE 7.28%
ROCE 8.52%
ROIC 6.73%
ROICexc 6.73%
ROICexgc 6.75%
OM 1.72%
PM (TTM) 1.44%
GM 12.19%
FCFM N/A
ROA(3y)-17.29%
ROA(5y)-20.7%
ROE(3y)-22.67%
ROE(5y)-27.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.4%
GM growth 5Y35.7%
F-ScoreN/A
Asset Turnover3.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 2.77
Altman-Z N/A
F-ScoreN/A
WACC8.52%
ROIC/WACC0.79
Cap/Depr(3y)21.03%
Cap/Depr(5y)18.67%
Cap/Sales(3y)0.55%
Cap/Sales(5y)0.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)441.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.62%
EPS Next Y531.48%
EPS Next 2Y231.38%
EPS Next 3Y180.68%
EPS Next 5YN/A
Revenue 1Y (TTM)27.94%
Revenue growth 3Y28.03%
Revenue growth 5Y32.94%
Sales Q2Q%27.1%
Revenue Next Year28.57%
Revenue Next 2Y26.78%
Revenue Next 3Y25.48%
Revenue Next 5YN/A
EBIT growth 1Y931.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.16%
EBIT Next 3Y38.86%
EBIT Next 5YN/A
FCF growth 1Y266.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y163.53%
OCF growth 3YN/A
OCF growth 5YN/A

ATRENEW INC / RERE FAQ

What is the fundamental rating for RERE stock?

ChartMill assigns a fundamental rating of 5 / 10 to RERE.


What is the valuation status for RERE stock?

ChartMill assigns a valuation rating of 4 / 10 to ATRENEW INC (RERE). This can be considered as Fairly Valued.


What is the profitability of RERE stock?

ATRENEW INC (RERE) has a profitability rating of 3 / 10.


What are the PE and PB ratios of ATRENEW INC (RERE) stock?

The Price/Earnings (PE) ratio for ATRENEW INC (RERE) is 28.21 and the Price/Book (PB) ratio is 2.11.


What is the expected EPS growth for ATRENEW INC (RERE) stock?

The Earnings per Share (EPS) of ATRENEW INC (RERE) is expected to grow by 531.48% in the next year.